Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mead

Showing results (401-410 of 435) with videos related to

Pageof 44
Sort By:
Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood|January 18, 2018
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesisSara Duarte, Petter S Woll, Natalija Buza-Vidas, et al.
Cell Stem Cell|February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disordersYuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve MyelofibrosisJohn Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
Cancer Research|November 3, 2023
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring SideroblastsPedro L Moura, Teresa Mortera-Blanco, Isabel J Hofman, et al.
Future Oncology (London, England)|August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosisClaire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
Nature Immunology|October 4, 2016
Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitorsTiago C Luis, Sidinh Luc, Takuo Mizukami, et al.
Cell Stem Cell|September 24, 2013
Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cellsCharlotta Böiers, Joana Carrelha, Michael Lutteropp, et al.
Pageof 44

Showing results (401-410 of 435) with videos related to

Sort By:
Pageof 44
Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood|January 18, 2018
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesisSara Duarte, Petter S Woll, Natalija Buza-Vidas, et al.
Cell Stem Cell|February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disordersYuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve MyelofibrosisJohn Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
Cancer Research|November 3, 2023
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring SideroblastsPedro L Moura, Teresa Mortera-Blanco, Isabel J Hofman, et al.
Future Oncology (London, England)|August 11, 2022
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosisClaire N Harrison, Vikas K Gupta, Aaron T Gerds, et al.
Nature Immunology|October 4, 2016
Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitorsTiago C Luis, Sidinh Luc, Takuo Mizukami, et al.
Cell Stem Cell|September 24, 2013
Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cellsCharlotta Böiers, Joana Carrelha, Michael Lutteropp, et al.
Pageof 44